TIDMAGR
RNS Number : 2417F
Assura PLC
06 July 2023
6 July 2023
Assura plc ("Company")
Result of AGM
Assura plc announces that at its Annual General Meeting held
earlier today, each of the resolutions submitted to the meeting (as
set out in the Notice of the Meeting dated 2 June 2023) were passed
by the requisite majorities on a poll.
Total Votes
Cast (%
% of issued Votes
Resolution For For Against % Against share capital) Withheld
1. To receive
the Company's
report and accounts 2,404,255,196 99.93 1,633,381 0.07 2,405,888,577(81.18) 1,591,592
2. To approve
the Directors'
Remuneration 2,395,367,903
Report 2,341,833,957 97.77 53,533,946 2.23 (80.82) 12,112,266
3. To re-appoint
Ernst & Young
LLP as auditor 2,407,430,623
of the Company 2,405,682,727 99.93 1,747,896 0.07 (81.23) 49,546
4. To authorise
the Audit Committee
to determine
the auditor's 2,407,456,956
remuneration 2,407,370,213 99.99 86,743 0.00 (81.23) 23,213
5. To re-elect
Ed Smith as
a Director of 2,346,669,946
the Company 2,233,952,170 95.20 112,717,776 4.80 (79.18) 60,810,223
6. To re-elect
Louise Fowler
as a Director 2,407,446,241
of the Company 2,383,530,756 99.01 23,915,485 0.99 (81.23) 33,928
7. To re-elect
Jonathan Murphy
as a Director 2,407,444,146
of the Company 2,399,732,255 99.68 7,711,891 0.32 (81.23) 36,023
8. To re-elect
Jayne Cottam
as a Director 2,407,447,156
of the Company 2,375,836,492 98.69 31,610,664 1.31 (81.23) 33,013
9. To re-elect
Jonathan Davies
as a Director 2,407,443,232
of the Company 2,384,867,137 99.06 22,576,095 0.94 (81.23) 36,937
10. To re-elect
Sam Barrell
as a Director 2,407,443,232
of the Company 2,384,892,936 99.06 22,550,296 0.94 (81.23) 36,937
11. To re-elect
Emma Cariaga
as a Director 2,407,443,232
of the Company 2,406,157,355 99.95 1,285,877 0.05 (81.23) 36,937
12. To re-elect
Noel Gordon
as a Director 2,407,443,232
of the Company 2,387,372,443 99.17 20,070,789 0.83 (81.23) 36,937
13. To authorise
the Directors 2,405,999,404
to allot shares 2,298,635,357 95.54 107,364,047 4.46 (81.18) 1,480,765
14. To empower
the Directors
to disapply
pre-emption
rights 2,377,573,799 98.82 28,407,039 1.18 2,405,980,838(81.18) 1,499,331
15. To empower
the Directors
to disapply
pre-emption
rights in connection
with an acquisition
or specified 2,401,211,737
capital investment 2,295,995,741 95.62 105,215,996 4.38 (81.02) 6,268,432
16. To authorise
the market purchase
of the Company's
own shares 2,405,270,604 99.99 290,670 0.01 2,405,561,274(81.17) 1,918,895
17. To authorise
the Company
to call any
general meeting,
other than the
Annual General
Meeting, by
not less than
14 clear days' 2,407,430,158
notice 2,277,947,643 94.62 129,482,515 5.38 (81.23) 50,011
Resolutions 1-13 were passed as ordinary resolutions.
Resolutions 14-17 were passed as special resolutions. Votes 'For'
include votes at the discretion of the Chairman.
Notes:
1. The percentages above are rounded to two decimal places.
2. A vote withheld is not a vote in law and is not counted in
the calculation of the proportion of votes "for" and "against" a
resolution.
3. The number of ordinary shares in issue on the share register
at 6.00pm on 5 July 2023 was 2,963,648,116 of which the Total
Voting Rights figure was 2,963,648,116.
Copies of resolutions 14-17, being resolutions other than
resolutions concerning ordinary business passed by the Company at
the above AGM, have been submitted to the National Storage
Mechanism and will shortly be available for inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
- Ends -
For more information, please contact:
Assura plc Tel: 01925 945354
Orla Ball, G eneral Counsel Email: Investor@assura.co.uk
David Purcell, Investor Relations
Director
FGS Global Tel: 0207 251 3801
Gordon Simpson Email: Assura@fgsglobal.com
James Thompson
Notes to Editors
Assura plc is a national healthcare premises specialist and UK
REIT based in Altrincham, UK - caring for more than 600 primary
healthcare buildings, from which over six million patients are
served.
A constituent of the FTSE 250 and the EPRA* indices, as at 31
March 2023, Assura's portfolio was valued at GBP2.7 billion.
At Assura, we BUILD for health. Assura builds better spaces for
people and places, invests in skills and inspires new ways of
working, and unlocks the power of design and innovation to deliver
lasting impact for communities - aiming for six million people to
have benefitted from improvements to and through its healthcare
buildings by 2026.
Assura is leading for a sustainable future, targeting net zero
carbon across its portfolio by 2040.
Further information is available at www.assuraplc.com
*EPRA is a registered trademark of the European Public Real
Estate Association.
Assura plc LEI code: 21380026T19N2Y52XF72
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RAGSSEFDMEDSELW
(END) Dow Jones Newswires
July 06, 2023 09:47 ET (13:47 GMT)
Assura (LSE:AGR)
Historical Stock Chart
From Apr 2024 to May 2024
Assura (LSE:AGR)
Historical Stock Chart
From May 2023 to May 2024
